No content results match your keyword.
Content
You have successfully logged out.
Not registered yet?
No content results match your keyword.
Content
No product results match your keyword.
Products
Oncology Closer To Home
B. Braun Medical Ltd support over 5,000 patients in the community per year across several therapies such as home parental nutrition, ostomy and continence supplies, home haemodialysis, antimicrobial therapy, and monoclonal antibodies.
We have a dedicated team of specialist nurses, pharmacists and customer care teams, all of whom pride themselves on providing a high-quality service you can trust.
Our aim is to support the patients’ individual needs, providing quality care closer to home.
B. Braun are working together with the NHS to ensure that patients receive seamless transitions from hospital to home, through the delivery of high-quality clinical care.
So... Join the journey with us!
In recent years, the increasing number of patients being diagnosed with cancer has been a growing pressure for the NHS[1]. Evidence suggests that within the next 20 years, the number of people living with cancer will increase from 3 million to 5.3 million, which is at odds with treatment capacity levels which are expected to remain static.
Despite the incredible efforts of the NHS to prevent backlog, an already growing rate of patient diagnosis, matched with the contribution of the pandemic, meant November 2022 saw the worst-ever waiting times for cancer treatment[2].
The introduction of the Faster Diagnosis Standard forces the rate at which patients are diagnosed after referral to increase[3]. For a patient waiting after referral, earlier diagnosis is desirable, however we can’t ignore that an increase in patients diagnosed earlier, leads to a much larger group waiting for, or receiving, treatment. Without a change to the number of chairs on chemotherapy units, hospitals may struggle to meet this increased treatment demand. This is evident as 29% of patients are experiencing delayed treatment, and 8% are being referred to a different hospital for their care[4].
Likely due to earlier diagnosis, new treatments, and a dedicated NHS, 5-year survival of UK patients with Lung, Stomach, Oesophagus and Pancreas Cancer is increasing[5]. Ultimately, rather than being relieved, pressure on the NHS has transferred from getting patients diagnosed, to getting them treated and maintaining this treatment. Demand for quantity and time in chairs is growing, and the current operating capacity could mean an acceleration in backlog, something we want to help support and address alongside the NHS.
B. Braun recognise the importance of national action to safeguard cancer services and increase capacity to ease the backlog. We want to ensure that the potential for therapeutic oncology advancements does not go untapped. If we efficiently work in partnership with the NHS to provide treatment and help improve capacity, both patients and the NHS alike will see significant benefits.
With an established team of specialist homecare nurses and a comprehensive product portfolio, B. Braun Medical has the ability to provide an oncology solution closer to patients’ homes.
B. Braun are looking at new ways to work with the NHS and develop tailored solutions to support healthcare challenges. With this in mind we are partnering with the NHS to deliver mobile oncology hub units, supporting the delivery of care to the ever growing demand of oncology treatment closer to the patient’s homes.
The aim of our service is to compliment and add value to your oncology service, offering a holistic approach to patient care, tailored to your needs and requirements, but ultimately working in partnership with you to ensure the patient is at the heart of the service.
[1] John, S. (2019) Geographic patterns of cancer survival in England: Adults diagnosed 2012 to 2016 and followed up to 2017, Geographic patterns of cancer survival in England - Office for National Statistics. Available at:https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/geographicpatternsofcancersurvivalinengland/adultsdiagnosed2012to2016andfollowedupto2017#toc (Accessed: 16 August 2023).
[2] Price, P. (2023) UK cancer care: A watershed moment and the need for urgent intervention, The Lancet. Available at: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(22)00754-9/fulltext (Accessed: 16 August 2023).
[3] Keane, D. (2023) Two-thirds of NHS cancer targets to be scrapped by autumn, Evening Standard. Available at: https://www.msn.com/en-gb/health/other/two-thirds-of-nhs-cancer-targets-to-be-scrapped-by-atumn/ar-AA1fmHpt (Accessed 4 September 2023)
[4] Macmillan (2020) The Forgotten ‘C’ on cancer care - Macmillan cancer support, Macmillan. Available at: https://www.macmillan.org.uk/dfsmedia/1a6f23537f7f4519bb0cf14c45b2a629/9601-10061/the-forgotten-c-the-impact-of-covid-on-cancer-care (Accessed: 16 August 2023).
[5] Searles, M. (2023) New cancer targets won’t help patients, says top oncologist, The Telegraph. Available at: https://www.telegraph.co.uk/news/2023/08/14/pat-price-cancer-oncology-charity-change-nhs-target-fail/ (Accessed 5 September 2023)
The personal data you provide on this form will be collected by B. Braun Medical Ltd in accordance with the Data Protection Act 2018 and UK GDPR.
This data may be sent to our third party customer database manager who will hold your data on EU servers and contact you to confirm your future marketing preferences. In providing your personal or business data you consent for such data to be used for the purpose of receiving contact about products and services from B. Braun Medical Ltd.
Please see the detailed Privacy Policy on our website: www.bbraun.co.uk or by clicking here.
Register or login below to access your personalised account, with applications and content tailored specifically to you and your speciality.